Gu HM - Search Results

1

[Breast cancer resistance protein and diabetes].

Liu HY, Gu HM, Yu S, Zhang XQ. Liu HY, et al. Among authors: gu hm. Sheng Li Ke Xue Jin Zhan. 2013 Apr;44(2):99-104. Sheng Li Ke Xue Jin Zhan. 2013. PMID: 23847919 Review. Chinese.

2

Anti-Helicobacter pylori compounds from the ethanol extracts of Geranium wilfordii.

Zhang XQ, Gu HM, Li XZ, Xu ZN, Chen YS, Li Y. Zhang XQ, et al. Among authors: gu hm. J Ethnopharmacol. 2013 May 2;147(1):204-7. doi: 10.1016/j.jep.2013.02.032. Epub 2013 Mar 7. J Ethnopharmacol. 2013. PMID: 23500884

3

Magnesium isoglycyrrhizinate ameliorates fructose-induced podocyte apoptosis through downregulation of miR-193a to increase WT1.

Li TS, Chen L, Wang SC, Yang YZ, Xu HJ, Gu HM, Zhao XJ, Dong P, Pan Y, Shang ZQ, Zhang XQ, Kong LD. Li TS, et al. Among authors: gu hm. Biochem Pharmacol. 2019 Aug;166:139-152. doi: 10.1016/j.bcp.2019.05.016. Epub 2019 May 11. Biochem Pharmacol. 2019. PMID: 31085161

4

Glycyrrhetinic Acid Protects α-Naphthylisothiocyanate- Induced Cholestasis Through Regulating Transporters, Inflammation and Apoptosis.

Yan M, Guo L, Yang Y, Zhang B, Hou Z, Gao Y, Gu H, Gong H. Yan M, et al. Front Pharmacol. 2021 Sep 24;12:701240. doi: 10.3389/fphar.2021.701240. eCollection 2021. Front Pharmacol. 2021. PMID: 34630081 Free PMC article.

5

Liquiritin alleviates alpha-naphthylisothiocyanate-induced intrahepatic cholestasis through the Sirt1/FXR/Nrf2 pathway.

Yan M, Guo L, Ma J, Yang Y, Tang T, Zhang B, Zhou W, Zou W, Hou Z, Gu H, Gong H. Yan M, et al. J Appl Toxicol. 2023 Mar;43(3):350-359. doi: 10.1002/jat.4385. Epub 2022 Sep 13. J Appl Toxicol. 2023. PMID: 36008890

6

Dataset on assessment of magnesium isoglycyrrhizinate injection for dairy diet and body weight in fructose-induced metabolic syndrome of rats.

Zhao XJ, Yang YZ, Zheng YJ, Wang SC, Gu HM, Pan Y, Wang SJ, Xu HJ, Kong LD. Zhao XJ, et al. Among authors: gu hm. Data Brief. 2018 Mar 8;18:69-75. doi: 10.1016/j.dib.2018.03.016. eCollection 2018 Jun. Data Brief. 2018. PMID: 29896493 Free PMC article.

7

Magnesium isoglycyrrhizinate blocks fructose-induced hepatic NF-κB/NLRP3 inflammasome activation and lipid metabolism disorder.

Zhao XJ, Yang YZ, Zheng YJ, Wang SC, Gu HM, Pan Y, Wang SJ, Xu HJ, Kong LD. Zhao XJ, et al. Among authors: gu hm. Eur J Pharmacol. 2017 Aug 15;809:141-150. doi: 10.1016/j.ejphar.2017.05.032. Epub 2017 May 17. Eur J Pharmacol. 2017. PMID: 28526339

8

Ameliorative effect of Magnesium Isoglycyrrhizinate on hepatic encephalopathy by Epirubicin.

Jiang W, Guo H, Su D, Xu H, Gu H, Hao K. Jiang W, et al. Int Immunopharmacol. 2019 Oct;75:105774. doi: 10.1016/j.intimp.2019.105774. Epub 2019 Jul 25. Int Immunopharmacol. 2019. PMID: 31351363

9

Magnesium isoglycyrrhizinate ameliorates high fructose-induced liver fibrosis in rat by increasing miR-375-3p to suppress JAK2/STAT3 pathway and TGF-β1/Smad signaling.

Yang YZ, Zhao XJ, Xu HJ, Wang SC, Pan Y, Wang SJ, Xu Q, Jiao RQ, Gu HM, Kong LD. Yang YZ, et al. Among authors: gu hm. Acta Pharmacol Sin. 2019 Jul;40(7):879-894. doi: 10.1038/s41401-018-0194-4. Epub 2018 Dec 19. Acta Pharmacol Sin. 2019. PMID: 30568253 Free PMC article.

10

Author Correction: Magnesium isoglycyrrhizinate ameliorates high fructose-induced liver fibrosis in rat by increasing miR-375-3p to suppress JAK2/STAT3 pathway and TGF-β1/Smad signaling.

Yang YZ, Zhao XJ, Xu HJ, Wang SC, Pan Y, Wang SJ, Xu Q, Jiao RQ, Gu HM, Kong LD. Yang YZ, et al. Among authors: gu hm. Acta Pharmacol Sin. 2022 Jun;43(6):1616. doi: 10.1038/s41401-021-00771-9. Acta Pharmacol Sin. 2022. PMID: 34493815 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page